0 Commentaires
0 Parts
1KB Vue
0 Aperçu
Commandité
Annuaire
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Connectez-vous pour aimer, partager et commenter!
-
Radioligand Therapy Revolution: CI Insights into the Future of Precision OncologyRadioligand therapy (RLT) combines tumor-specific ligands with radioisotopes to deliver highly targeted radiation to cancer cells with minimal impact on healthy tissues. Founded on a precision innovation model in hemophilia B, RLT is transforming the treatment of metastatic and refractory cancers. With recent clinical approvals and an expanding global pipeline, RLT promises sustained innovation...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
North America Leads Gene Therapy Surge with 24% CAGRGene Therapy Market Set to Expand to USD 29–55 Billion by 2033–2034 The Gene Therapy Market, valued at approximately USD 8–9 billion in 2024, is projected to grow at a compound annual growth rate (CAGR) of 18–20%, reaching between USD 29 and 55 billion by 2033–34. This dynamic expansion is driven by a growing pipeline of oncology and rare disease therapies,...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Home Brewing Equipment Spurs Retail BoomThe global coffee market is expected to grow from USD 269.3 billion in 2024 to USD 369.5 billion by 2030, registering a compound annual growth rate (CAGR) of 5.3%. The growth is primarily driven by a rising demand for specialty beverages, increasing home brewing, ethical sourcing practices, and robust expansion across Asia-Pacific economies. Market Overview 2024 Global Market: USD 269.3...0 Commentaires 0 Parts 2KB Vue 0 Aperçu
-
Price Trends & Forecast: Global Camel Meat Export Prices Rise in 2024Market Size & Forecast The camel meat market is expected to grow at a Compound Annual Growth Rate (CAGR) of 5.5% during the forecast period (2024–2031). Starting from a valuation of approximately USD 1.6 billion in 2023, the market is forecast to reach around USD 2.33 billion by 2030. This growth is driven by a combination of factors: Consumer demand for nutritious and exotic meats...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Rapid Growth Ahead for Biofuel Enzymes Amid Global MandatesThe Biofuel Enzymes Market is advancing rapidly, fueled by expanding renewable fuel mandates, breakthroughs in enzyme technologies, and increased demand for sustainable energy sources. Enzymes such as cellulases, lipases, and amylases are critical biocatalysts that convert biomass into bioethanol, biodiesel, and biogas helping reduce greenhouse gas emissions and enable clean-energy access. To...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Gaucher’s Disease Uncovered: CI Insights into Therapies, Pipelines, and Market TrendsGaucher’s Disease, a rare lysosomal storage disorder, is entering a new era of targeted therapies and patient-centered treatment. No longer managed solely by biweekly enzyme replacement, the field is evolving with oral agents, precision diagnostics, and the promise of gene therapy. As clinical science advances, Gaucher’s Disease is emerging as a model for rare genetic disease...0 Commentaires 0 Parts 987 Vue 0 Aperçu
-
U.S. Biotech Surge Fuels Exosome-Based Liquid Biopsy DevelopmentThe global exosomes market reached US$ 1.3 billion in 2023 and is projected to grow to US$ 2.7 billion by 2031, at a CAGR of 15.6% during the forecast period 2024–2031, driven by expanding applications in oncology, immunotherapy, and regenerative medicine. Exosomes small vesicles ranging from 30 to 200 nm—mediate critical intercellular signaling, including EGFR-related mechanisms...0 Commentaires 0 Parts 2KB Vue 0 Aperçu
-
Rising Pet Ownership Drives Veterinary Pain *** Demand GloballyThe Veterinary Pain Management ***s market is forecast to grow from approximately USD 2.5 billion in 2024 to USD 3.82 billion by 2030, registering a steady CAGR of 6.8%. The growth is fueled by increasing pet ownership, a rise in chronic conditions like osteoarthritis and cancer among animals, greater adoption of pet insurance, and the launch of advanced treatment options including monoclonal...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Stargardt Disease in Focus: CI Insights into Emerging Therapies and Pipeline InnovationStargardt disease, a rare genetic eye disorder, is emerging as a key focus in retinal therapeutics. With no approved cure yet available, this inherited form of macular degeneration primarily affects children and young adults, progressively reducing central vision. However, advancements in gene therapy, stem cell technology, and disease-modifying interventions are ushering in a new era of hope....0 Commentaires 0 Parts 1KB Vue 0 Aperçu
Commandité
© 2025 Friends - Best Social Network - החברים - רשת חברתית
French
French
English
Arabic
עברית
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek